[期刊]
  • 《American Journal of Physiology》 2016年310卷4 Pt.2期

摘要 : Transforming growth factor-beta (TGF-beta) is generally considered as a central mediator of fibrotic diseases. Indeed, much focus has been placed on inhibiting TGF-beta and its downstream targets as ideal therapeutic strategies. H... 展开

相关作者
相关关键词